Anionic charge sites in the kidney: comparison of two diabetic rat models.
The distribution and appearance of anionic charge sides (ACS) in the glomerular basement membrane (GBM) and mesangium were studied in two different animal models of diabetes mellitus (DM), the obese Zucker rat as an animal model of type 2 diabetes mellitus (DM) and streptozocin-induced Sprague-Dawley rat as an animal model of type 1 DM. Four obese Zucker rats (ZR) and four Sprague-Dawley rats were analyzed for the following parameters: number of ACS per length of lamina rara externa (LRE), (ACS/LRE); number of ACE per length of lamina rara interna (LRI) (ACS/LRI); percent of mesangial matrix as ACS (%MMACS); percent of LRE as ACS (%LREACS); percent of LRI as ACS (%LRIACS); length of ACS in LRI (LACSLRI); length of ACS in LRE (LACSLRE); width of ACS in LRI (WACSLRI); width of ACS in the LRE (WACSLRE); area of ACS in the LRI (AACSLRI); and the area of ACS in the LRE (AACSLRE). Statistical analyses include a one-way analysis of variance (ANOVA), Pearson's correlation coefficient, and stepwise multiple regression. This study confirms that a loss of ACS occurs as proteinuria develops in a variety of animal models. The majority of the ACS were more prominently localized, and thus lost form the LRE of the GBM in DN. This study also demonstrated that defined alterations in the glomerular ACS can be identified early in the evolution of DN in both animal models, and that the similarity of the changes in the ACS suggest that a common pathophysiologic mechanism induced the changes in both animal models.
Ward-Cook
K M
KM
The Ohio State University, Springfield Community Hospital, USA.
Mahan
J D
JD
Frenchko
C E
CE
Albright
A
A
Chiasera
J M
JM
McAllister
C
C
D000818:Animals; D000838:Anions / Q000032:analysis*; D001485:Basement Membrane / Q000473:pathology; D001786:Blood Glucose / Q000032:analysis; D004396:Coloring Agents; D003921:Diabetes Mellitus, Experimental / Q000503:physiopathology*; D003922:Diabetes Mellitus, Type 1 / Q000503:physiopathology*; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology*; D003928:Diabetic Nephropathies / Q000503:physiopathology; D004195:Disease Models, Animal; D005920:Glomerular Mesangium / Q000473:pathology; D017127:Glycation End Products, Advanced / Q000032:analysis; D007677:Kidney Function Tests; D007678:Kidney Glomerulus / Q000473:pathology* / Q000648:ultrastructure; D051381:Rats; D017207:Rats, Sprague-Dawley; D011924:Rats, Zucker
D000838:Anions; D001786:Blood Glucose; D004396:Coloring Agents; D017127:Glycation End Products, Advanced